Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Limited has filed its unaudited financial results for the quarter and half-year ended September 30, 2025 with the stock exchange as part of standard regulatory compliance under listing obligations. The filing itself does not contain the detailed financial numbers, segment breakdown, or auditor observations in this headline. Investors need to refer to the actual results PDF to assess revenue, profit, margins, and any auditor qualifications or emphasis of matter.
This is a routine compliance filing and not an event-driven announcement, so no immediate price catalyst is expected. Shareholders should review the detailed results document for actual performance trends, auditor remarks, and any exceptional items before drawing conclusions.